机译:工程化MIPI(E-MIPI),一种候选数据采矿的基于基于型的搭腔细胞淋巴瘤预后指数,从Fondazione Italiana Linfomi(Fil)MCL0208期III试验
Univ Turin Div Hematol Dept Mol Biotechnol &
Hlth Sci Turin Italy;
Univ Turin Div Hematol Dept Mol Biotechnol &
Hlth Sci Turin Italy;
Univ Torino Div Nucl Med Turin Italy;
Citta Salute &
Sci Unit Clin Epidemiol Turin Italy;
Univ Turin Div Hematol Dept Mol Biotechnol &
Hlth Sci Turin Italy;
Univ Turin Div Hematol Dept Mol Biotechnol &
Hlth Sci Turin Italy;
Politecn Torino Dept Elect &
Telecommun Turin Italy;
Univ Turin Div Hematol Dept Mol Biotechnol &
Hlth Sci Turin Italy;
IRCCS Ctr Riferimento Oncol Clin &
Expt Oncohematol Unit Aviano Italy;
IRCCS Ctr Riferimento Oncol Clin &
Expt Oncohematol Unit Aviano Italy;
Univ Torino Unit Canc Epidemiol Turin Italy;
Santa Maria delle Croci Hosp Hematol Unit Ravenna Italy;
Amedeo Avogadro Univ Eastern Piedmont Dept Translat Med Novara Italy;
Univ Udine Clin Ematol Ctr Trapianti &
Terapie Cellulari C Melzi DAME Udine Italy;
Osped Oncol Armando Businco Div Hematol Cagliari Italy;
Vito Fazzi Hosp Hematol Lecce Italy;
Univ Modena &
Reggio Emilia Clin &
Publ Hlth Arcispedale S Maria Nuova Hematol Div Dept Diagnost;
Guglielmo da Saliceto Hosp Div Hematol Piacenza Italy;
Nation Canc Inst Div Med Oncol Aviano Italy;
Azienda ULSS 3 Serenissima Div Hematol Venice Italy;
Osped San Francesco Unita Ematol &
Trapianto Midollo Osseo Nuoro Italy;
Azienda Osped Riuniti Villa Sofia Cervello Div Hematol 1 Palermo Italy;
Univ Trieste Maggiore Gen Hosp Dept Internal Med &
Haematol Trieste Italy;
Azienda Osped Univ Senese Div Hematol Dept Oncol Siena Italy;
Clin Humanitas Gavazzeni Bergamo Italy;
Azienda Osped SS Antonio &
Biagio &
Cesare Arrigo Div Hematol Alessandria Italy;
机译:工程化MIPI(E-MIPI),一种候选数据采矿的基于基于型的搭腔细胞淋巴瘤预后指数,从Fondazione Italiana Linfomi(Fil)MCL0208期III试验
机译:欧元克隆性下一代测序的标志性筛选方法检测甲状腺细胞淋巴瘤患者免疫球蛋白重链重排:Fondazione Italiana Linfomi MCL0208试验中的第一数据
机译:B-IGEV(硼替佐米加IGEV)与IGEV对比大剂量化疗后再进行自体干细胞移植治疗复发性或难治性霍奇金淋巴瘤:Fondazione Italiana Linfomi(FIL)的一项随机II期试验
机译:地幔细胞淋巴瘤中的二线利妥昔单抗来那度胺和苯达莫司汀:Fondazione Italiana Linfomi的II期临床试验
机译:KMT2D和TP53突变预测接受高剂量治疗和ASCT中的披风细胞淋巴瘤中的PFS和OS:FOOLAZIONE ITALIANA LINFOMI(FIL)MCL0208期III试验